Pharmacologic magnetic resonance imaging (phMRI)

Biomedical Imaging in Experimental Neuroscience

Volumn , Issue , 2002, Pages 155-209

  Jenkins, Bruce G ^a   Iris Chen, Yin Ching ^a   Mendeville, Joseph B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85057662542     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (157)

1. Belliveau, J.W. et al., Functional mapping of the human visual cortex by magnetic resonance imaging, Science, 254, 716, 1991.
2. Kwong, K.K. et al., Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation, Proc. Natl. Acad. Sci. U.S.A., 89, 5675, 1992.
3. Ogawa, S. et al., Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging, Proc. Natl. Acad. Sci. U.S.A., 89, 5951, 1992.
4. Carlsson, C., Hagerdal, M., and Siesjo, B.K., Influence of amphetamine sulfate on cerebral blood flow and metabolism, Acta Physiol. Scand, 94, 128, 1975.
5. Chen, Y.I. et al., Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data, Mag. Res. Med, 38, 389, 1997.
6. Silva, A.D. et al., Multislice MRI of rat brain during amphetamine stimulation using arterial spin labelling, Mag. Res. Med., 33, 1995.
7. Zhang, Z. et al., Pharmacological MRI mapping of age-associated changes in basal ganglia circuitry of awake rhesus monkeys, Neuroimage, 14, 1159, 2001.
8. Chen, Y.I. et al., Detection of dopaminergic cell loss and neural transplantation using pharmacological MRI, PET and behavioral assessment, Neuroreport, 10, 2881, 1999.
9. Marota, J.J. et al., Cocaine activation discriminates dopaminergic projections by temporal response: an fMRI study in rats, Neuroimage, 11, 13, 2000.
10. Chen, Q. et al., Mapping drug-induced changes in cerebral R2* by multiple gradient recalled echo functional MRI, Mag. Res. Imaging, 14, 469, 1996.
11. Zhang, Z. et al., Functional MRI of apomorphine activation of the basal ganglia in awake rhesus monkeys, Brain Res., 852, 290, 2000.
12. Nguyen, T.V. et al., Detection of the effects of dopamine receptor supersensitivity using pharmacological MRI and correlations with PET, Synapse, 36, 57, 2000.
13. Stein, E.A. et al., Nicotine-induced limbic cortical activation in the human brain: a functional MRI study, Am. J. Psychiatr., 155, 1009, 1998.
14. Xu, H. et al., Heroin-induced neuronal activation in rat brain assessed by functional MRI, Neuroreport, 11, 1085, 2000.
15. Scanley, B.E., Kennan, R.P, and Gore, J.C., Changes in rat cerebral blood volume due to modulation of the 5-HT(1A) receptor measured with susceptibility enhanced contrast MRI, Brain Res., 913, 149, 2001.
16. Kimberg, D.Y. et al., Cortical effects of bromocriptine, a D-2 dopamine receptor agonist, in human subjects, revealed by fMRI, Hum. Brain Mapping, 12, 246, 2001.
17. Schalling, M. et al., Comparison of gene expression of the dopamine D-2 receptor and DARPP-32 in rat brain, pituitary and adrenal gland, Eur. J. Pharmacol., 188, 277, 1990.
18. Pompeiano, M., Palacios, J.M., and Mengod, G., Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding, J. Neurosci., 12, 440, 1992.
19. Palacios, J.M. et al., Recent trends in receptor analysis techniques and instrumentation, J. Chem. Neuroanat., 4, 343, 1991.
20. Knull, H.R., Association of glycolytic enzymes with particulate fractions from nerve endings, Biochim. Biophys. Acta, 522, 1, 1978.
21. Knull, H.R. and Fillmore, S.J., Glycolytic enzyme levels in synaptosomes, Comp. Biochem. Physiol. B, 81, 349, 1985.
22. Knull, H. and Minton, A.P, Structure within eukaryotic cytoplasm and its relationship to glycolytic metabolism, Cell Biochem. Funct., 14, 237, 1996.
23. Kadekaro, M., Crane, A.M., and Sokoloff, L., Differential effects of electrical stimulation of sciatic nerve on metabolic activity in spinal cord and dorsal root ganglion in the rat, Proc. Natl. Acad. Sci. U.S.A.., 82, 6010, 1985.
24. Sokoloff, L., Measurement of local cerebral glucose utilization and its relation to local functional activity in the brain, Adv. Exp. Med. Biol., 291, 21, 1991.
25. Sokoloff, L., Sites and mechanisms of function-related changes in energy metabolism in the nervous system, Dev. Neurosci., 15, 194, 1993.
26. Pellerin, L. and Magistretti, PJ., Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization, Proc. Natl. Acad. Sci. U.S.A, 91, 10625, 1994.
27. Pellerin, L. and Magistretti, PJ., Excitatory amino acids stimulate aerobic glycolysis in astrocytes via an activation of the Na+/K+ ATPase, Dev. Neurosci., 18, 336, 1996.
28. Magistretti, PJ., Cellular bases of functional brain imaging: insights from neuron-glia metabolic coupling, Brain Res., 886, 108, 2000.
29. Sokoloff, L. et al., Contribution of astroglia to functionally activated energy metabolism, Dev. Neurosci., 18, 344, 1996.
30. Stella, N. et al., Glutamate-evoked release of arachidonic acid from mouse brain astrocytes, J. Neurosci., 14, 568, 1994.
31. Sorg, O. and Magistretti, PJ., Characterization of the glycogenolysis elicited by vasoactive intestinal peptide, noradrenaline and adenosine in primary cultures of mouse cerebral cortical astrocytes, Brain Res., 563, 227, 1991.
32. Cooper, J.R., Bloom, F.E., and Roth, R.H., The Biochemical Basis of Neuropharmacology, Oxford University Press, New York, 1996.
33. Lindvall, O., Ingvar, M., and Stenevi, U., Effects of methamphetamine on blood flow in the caudate-putamen after lesions of the nigrostriatal dopaminergic bundle in the rat, Brain Res., 211, 211, 1981.
34. Lyons, D. and Porrino, L.J., Dopamine depletion in the rostral nucleus accumbens alters the cerebral metabolic response to cocaine in the rat, Brain Res., 753, 69, 1997.
35. Iadecola, C., Regulation of the cerebral microcirculation during neural activity: is nitric oxide the missing link?Trends Neurosci., 16, 206, 1993.
36. Fillenz, M. et al., The role of astrocytes and noradrenaline in neuronal glucose metabolism, Acta Physiol. Scand., 167, 275, 1999.
37. Faraci, F.M. and Brian, J.E., Jr., Nitric oxide and the cerebral circulation, Stroke, 25, 692, 1994.
38. Cohen, Z. et al., Serotonin in the regulation of brain microcirculation, Progr. Neuro-biol., 50, 335, 1996.
39. Sato, A. and Sato, Y., Cholinergic neural regulation of regional cerebral blood flow, Alzheimer Dis. Assoc. Disorders, 9, 28, 1995.
40. Vaucher, E., Linville, D., and Hamel, E., Cholinergic basal forebrain projections to nitric oxide synthase-containing neurons in the rat cerebral cortex, Neuroscience, 79, 827, 1997.
41. El Husseiny, A. and Hamel, E., Muscarinic — but not nicotinic — acetylcholine receptors mediate a nitric oxide-dependent dilation in brain cortical arterioles: a possible role for the M5 receptor subtype, J. Cereb. Blood Flow Metabol, 20, 298, 2000.
42. Barbelivien, A. et al., Neurochemical stimulation of the rat substantia innominata increases cerebral blood flow (but not glucose use) through the parallel activation of cholinergic and non-cholinergic pathways, Brain Res., 840, 115, 1999.
43. Head, R.J. et al., Isolated brain microvessels: preparation, morphology, histamine and catecholamine contents, Blood Vessels, 17, 173, 1980.
44. Jones, B.E., Relationship between catecholamine neurons and cerebral blood vessels studied by their simultaneous fluorescent revelation in the rat brainstem, Brain Res. Bull, 9, 33, 1982.
45. Krimer, L.S. et al., Dopaminergic regulation of cerebral cortical microcirculation, Nature Neurosci., 1, 286, 1998.
46. Nehlig, A., Daval, J.L., and Debry, G., Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects, Brain Res. Rev, 17, 139, 1992.
47. Gulbenkian, S., Uddman, R., and Edvinsson, L., Neuronal messengers in the human cerebral circulation, Peptides, 22, 995, 2001.
48. Orzi, F. et al., Comparative effects of acute and chronic administration of amphetamine on local cerebral glucose utilization in the conscious rat, J. Cereb. Blood Flow Metabol., 3, 154, 1983.
49. Trugman, J.M. and James, C.L., D1 dopamine agonist and antagonist effects on regional cerebral glucose utilization in rats with intact dopaminergic innervation, Brain Res., 607, 270, 1993.
50. Wechsler L.R., Sokoloff L., Effects of d- and l-amphetamine on local cerebral glucose utilization in the conscious rat, J. Neurochem, 32, 15, 1979.
51. Jones, S.R. et al., Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter, J. Neurosci., 18, 1979, 1998.
52. Sulzer, D., Maidment, N.T., and Rayport, S., Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons, J. Neurochem., 60, 527, 1993.
53. Ferre, S. et al., Antagonistic interaction between adenosine A2A receptors and dopamine D2 receptors in the ventral striopallidal system: implications for the treatment of schizophrenia, Neuroscience, 63, 765, 1994.
54. Latini, S. et al., A2 adenosine receptors: their presence and neuromodulatory role in the central nervous system, Gen. Pharmacol., 27, 925, 1996.
55. Sebastiao, A.M. and Ribeiro, J.A., Adenosine A2 receptor-mediated excitatory actions on the nervous system, Progr. Neurobiol., 48, 167, 1996.
56. Le Moine, C. et al., Dopamine-adenosine interactions in the striatum and the globus pallidus: inhibition of striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects on c-fos expression, J. Neurosci, 17, 8038, 1997.
57. Pollack, A.E. et al., Differential localization of A2a adenosine receptor mRNA with D1 and D2 dopamine receptor mRNA in striatal output pathways following a selective lesion of striatonigral neurons, Brain Res., 631, 161, 1993.
58. Schiffmann, S.N. and Vanderhaeghen, J.J., Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons, J. Neurosci., 13, 1080, 1993.
59. Ferre, S. et al., Dopamine D1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopeduncular pathway and its modulation by adenosine A1 receptor-mediated mechanisms, Eur. J. Neurosci., 8, 1545, 1996.
60. Misra, A.L., Vadlamani, N.L., and Pontani, R.B., Effect of caffeine on cocaine locomotor stimulant activity in rats, Pharmacol. Biochem. Behav., 24, 761, 1986.
61. Herrera-Marschitz, M., Casas, M., and Ungerstedt, U., Caffeine produces contralateral rotation in rats with unilateral dopamine denervation: comparisons with apomor-phine-induced responses, Psychopharmacology, 94, 38, 1988.
62. Pollack, A.E. and Fink, J.S., Synergistic interaction between an adenosine antagonist and a D1 dopamine agonist on rotational behavior and striatal c-Fos induction in 6-hydroxydopamine-lesioned rats, Brain Res., 743, 124, 1996.
63. Ferre, S. et al., The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain, J. Neurosci., 13, 5402, 1993.
64. Villringer, A. et al., Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects, Magn. Res. Med., 6, 164, 1988.
65. Frank, J.A. et al., Measurement of relative cerebral blood volume changes with visual stimulation by “double-dose” gadopentetate-dimeglumine-enhanced dynamic magnetic resonance imaging, Invest. Radiol., 29, Suppl 2, S157, 1994.
66. Henriksen, L., Paulson, O.B., and Lassen, N.A., Visual cortex activation recorded by dynamic emission computed tomography of inhaled xenon 133, Eur. J. Nucl. Med., 6, 487, 1981.
67. [18F]fluorodeoxyglucose technique, Science, 212, 678, 1981.
68. Phelps, M.E., Positron computed tomography studies of cerebral glucose metabolism in man: theory and application in nuclear medicine, Semin. Nucl. Med., 11, 32, 1981.
69. Mazziotta, J.C. et al., Tomographic mapping of human cerebral metabolism: auditory stimulation, Neurology, 32, 921, 1982.
70. Baron, J.C. et al., Noninvasive measurement of blood flow, oxygen consumption, and glucose utilization in the same brain regions in man by positron emission tomography: concise communication, J. Nucl. Med., 23, 391, 1982.
71. Lassen, N.A. and Ingvar, D.H., Brain regions involved in voluntary movements as revealed by radioisotopic mapping of CBF or CMR-glucose changes, Rev. Neurol. (Paris), 146, 620, 1990.
72. Fox, PT. et al., Nonoxidative glucose consumption during focal physiologic neural activity, Science, 241, 462, 1988.
73. Grafton, S.T., PET: activation of cerebral blood flow and glucose metabolism, Adv. Neurol., 83, 87, 2000.
74. Singer, J.R., Blood flow rates by nuclear magnetic resonance measurements, Science, 130, 1652, 1959.
75. Dixon, W.T. et al., Projection angiograms of blood labeled by adiabatic fast passage, Magn. Res. Med., 3, 454, 1986.
76. Detre, J.A., Leigh, J.S., Williams, D.S., and Koretsky, A.P, Perfusion Imaging, Mag. Res. Med, 23, 37, 1992.
77. Ogawa, S. et al., Brain magnetic resonance imaging with contrast dependent on blood oxygenation, Proc. Natl. Acad. Sci. U.S.A., 87, 9868, 1990.
78. Turner, R. et al., Echo-planar time course MRI of cat brain oxygenation changes, Mag. Res. Med., 22, 159, 1991.
79. Bandettini, PA. et al., Time course EPI of human brain function during task activation, Mag. Res. Med., 25, 390, 1992.
80. Davis, T.L. et al., Calibrated functional MRI: mapping the dynamics of oxidative metabolism, Proc. Natl. Acad. Sci. U.S.A., 95, 1834, 1998.
81. (2) during rat forepaw stimulation, Mag. Res. Med., 42, 944, 1999.
82. Hoge, R.D. et al., Investigation of BOLD signal dependence on cerebral blood flow and oxygen consumption: the deoxyhemoglobin dilution modelMag. Res. Med., 42, 849, 1999.
83. Ogawa, S., Lee, R.M., and Barrere, B., The sensitivity of magnetic resonance image signals of a rat brain to changes in the cerebral venous blood oxygenation, Mag. Res. Med., 29, 205, 1993.
84. Fox, PT. and Raichle, M.E., Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects, Proc. Natl. Acad. Sci. U.S.A., 83, 1140, 1986.
85. [13C] nuclear magnetic resonance study, J. Cereb. Blood Flow Metabol., 17, 1040, 1997.
86. [13C]NMR, Proc. Natl. Acad. Sci. U.S.A., 93, 7612, 1996.
87. (13)C] MRS and fMRI, Mag. Res. Med., 45, 349, 2001.
88. Chen, Y.C. et al., Improved mapping of pharmacologically induced neuronal activation using the IRON technique with superparamagnetic blood pool agents, J. Mag. Res. Imaging, 14, 517, 2001.
89. van Bruggen, N. et al., High-resolution functional magnetic resonance imaging of the rat brain: mapping changes in cerebral blood volume using iron oxide contrast media, J. Cereb. Blood Flow Metabol., 18, 1178, 1998.
90. Mandeville, J.B. et al., Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation, Mag. Res. Med., 39, 615, 1998.
91. Kennan, R.P et al., Physiological basis for BOLD MR signal changes due to neuronal stimulation: separation of blood volume and magnetic susceptibility effects, Mag. Res. Med, 40, 840, 1998.
92. Mandeville, J.B. et al., Regional sensitivity and coupling of BOLD and CBV changes during stimulation of rat brain, Mag. Res. Med., 45, 443, 2001.
93. Taylor, A.M. et al., Use of the intravascular contrast agent NC100150 injection in spin-echo and gradient-echo imaging of the heart, J. Cardiovasc. Mag. res., 1, 23, 1999.
94. Saini, S. et al., Multicentre dose-ranging study on the efficacy of USPIO ferumoxtran-10 for liver MR imaging, Clin. Radiol., 55, 690, 2000.
95. Boxerman, J.L. et al., The intravascular contribution to fMRI signal change: Monte Carlo modeling and diffusion-weighted studies in vivo, Mag. Res. Med., 34, 4, 1995.
96. Biswal, B., DeYoe, A.E., and Hyde, J.S., Reduction of physiological fluctuations in fMRI using digital filters, Mag. Res. Med., 35, 107, 1996.
97. Buonocore, M.H. and Maddock, R.J., Noise suppression digital filter for functional magnetic resonance imaging based on image reference data, Mag. Res. Med., 38, 456, 1997.
98. Purdon, PL. and Weisskoff, R.M., Effect of temporal autocorrelation due to physiological noise and stimulus paradigm on voxel-level false-positive rates in fMRI, Hum. Brain Mapping, 6, 239, 1998.
99. Prichard, J. et al., Lactate rise detected by 1H NMR in human visual cortex during physiologic stimulation, Proc. Natl. Acad. Sci. U.S.A., 88, 5829, 1991.
100. (13)C magnetic resonance spectroscopy, J. Neurosci. Res., 66, 737, 2001.
101. Merboldt, K.D. et al., Decrease of glucose in the human visual cortex during photic stimulation, Mag. Res. Med., 25, 187, 1992.
102. Gruetter, R. et al., Observation of resolved glucose signals in 1H NMR spectra of the human brain at 4 Tesla, Mag. Res. Med., 36, 1, 1996.
103. Mason, G.F. et al., Simultaneous determination of the rates of the TCA cycle, glucose utilization, a-ketoglutarate/glutamate exchange, and glutamine synthesis in human brain by NMR, J. Cereb. Blood Flow Metabol., 15, 12, 1995.
104. Gruetter, R., Seaquist, E.R., and Ugurbil, K., A mathematical model of compartmentalized neurotransmitter metabolism in the human brain, Am. J. Physiol. Endocrinol. Metabol, 281, E100, 2001.
105. Posse, S. et al., In vivo measurement of regional brain metabolic response to hyperventilation using magnetic resonance: proton echo planar spectroscopic imaging (PEPSI), Mag. Res. Med., 37, 858, 1997.
106. Guimaraes, A.R. et al., Echoplanar chemical shift imaging, Mag. Res. Med., 41, 877, 1999.
107. Loubinoux, I. et al., Cerebral metabolic changes induced by MK-801: a 1D (phosphorus and proton) and two-dimensional (proton) in vivo NMR spectroscopy study, Brain Res., 643, 115, 1994.
108. Petroff, O.A., and Rothman, D.L., Measuring human brain GABA in vivo: effects of GABA-transaminase inhibition with vigabatrin, Mol. Neurobiol., 16, 97, 1998.
109. 13C MRS in rat brain, in Proc. Intl. Soc. Mag. Res. Med., 1998, p. 1362.
110. Lin, Y.J. and Koretsky, A.P, Manganese ion enhances T1-weighted MRI during brain activation: an approach to direct imaging of brain function, Mag. Res. Med., 38, 378, 1997.
111. Duong, T.Q. et al., Functional MRI of calcium-dependent synaptic activity: cross correlation with CBF and BOLD measurements, Mag. Res. Med., 43, 383, 2000.
112. Verity, M.A., Manganese neurotoxicity: a mechanistic hypothesis, Neurotoxicology, 20, 489, 1999.
113. Weckesser, M. et al., Functional imaging of the visual cortex with bold-contrast MRI: hyperventilation decreases signal response, Mag. Res. Med., 41, 213, 1999.
114. Gollub, R.L. et al., Cocaine decreases cortical cerebral blood flow but does not obscure regional activation in functional magnetic resonance imaging in human subjects, J. Cereb. Blood Flow Metabol., 18, 724, 1998.
115. Zaharchuk, G. et al., Cerebrovascular dynamics of autoregulation and hypoperfusion. An MRI study of CBF and changes in total and microvascular cerebral blood volume during hemorrhagic hypotension, Stroke, 30, 2197, 1999.
116. Kalisch, R. et al., Blood pressure changes induced by arterial blood withdrawal influence bold signal in anesthesized rats at 7 Tesla: implications for pharmacologic MRI, Neuroimage, 14, 891, 2001.
117. Stullken, E.H., Jr. et al., The nonlinear responses of cerebral metabolism to low concentrations of halothane, enflurane, isoflurane, and thiopental, Anesthesiology, 46, 28, 1977.
118. Lindauer, U., Villringer, A., and Dirnagl, U., Characterization of CBF response to somatosensory stimulation: model and influence of anesthetics, Am. J. Physiol., 264, H1223, 1993.
119. Hara, K. and Harris, R.A., The anesthetic mechanism of urethane: the effects on neurotransmitter-gated ion channels, Anesth. Analg, 94, 313, 2002.
120. Anis, N.A. et al., The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate, Br. J. Pharmacol., 79, 565, 1983.
121. Thomson, A.M., West, D.C., and Lodge, D., An N-methylaspartate receptor-mediated synapse in rat cerebral cortex: a site of action of ketamine?Nature, 313, 479, 1985.
122. Hancock, PJ. and Stamford, J.A., Stereospecific effects of ketamine on dopamine efflux and uptake in the rat nucleus accumbens, Br. J. Anaesth., 82, 603, 1999.
123. Ueki, M., Mies, G., and Hossmann, K.A., Effect of a-chloralose, halothane, pentobarbital and nitrous oxide anesthesia on metabolic coupling in somatosensory cortex of rat, Acta Anaesthesiol. Scand., 36, 318, 1992.
124. Nieoullon, A. and Dusticier, N., Effects of a-chloralose on the activity of the nigro-striatal dopaminergic system in the cat, Eur. J. Pharmacol., 65, 403, 1980.
125. Chen, Y.I. et al., Anesthetic filters for eliciting specific neurotransmitter effects in pharmacologic MRI, inProc. Intl. Soc. Mag. Res. Med., 2000, p. 967.
126. Kleven, M.S. et al., Effects of repeated injections of cocaine on D1 and D2 dopamine receptors in rat brain, Brain Res., 532, 265, 1990.
127. Letchworth, S.R. et al., Effects of chronic cocaine administration on dopamine transporter mRNA and protein in the rat, Brain Res., 750, 214, 1997.
128. Berntman, L. et al., Circulatory and metabolic effects in the brain induced by amphetamine sulphate, Acta Physiol. Scand., 102, 310, 1978.
129. Perese, D.A. et al., A 6-hydroxydopamine-induced selective Parkinsonian rat model, Brain Res., 494, 285, 1989.
130. Bjorklund, L.M. et al., Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model, Proc. Natl. Acad. Sci. U.S.A., 99, 2344, 2002.
131. Beauregard, M., Levesque, J., and Bourgouin, P, Neural correlates of conscious selfregulation of emotion, J. Neurosci., 21, RC165, 2001.
132. Koepp, M.J. et al., Evidence for striatal dopamine release during a video game, Nature, 393, 266, 1998.
133. Blood, A.J. and Zatorre, R.J., Intensely pleasurable responses to music correlate with activity in brain regions implicated in reward and emotion, Proc. Natl. Acad. Sci. U.S.A., 98, 11818, 2001.
134. Loubinoux, I. et al., Cerebral functional magnetic resonance imaging activation modulated by a single dose of the monoamine neurotransmission enhancers fluoxetine and fenozolone during hand sensorimotor tasks, J. Cereb. Blood Flow Metabol., 19, 1365, 1999.
135. Sell, L.A. et al., Functional magnetic resonance imaging of the acute effect of intravenous heroin administration on visual activation in long-term heroin addicts: results from a feasibility study, Drug Alcohol Depend., 49, 55, 1997.
136. Uftring, S.J. et al., An fMRI study of the effect of amphetamine on brain activity, Neuropsychopharmacology, 25, 925, 2001.
137. Breiter, H.C. et al., Functional imaging of neural responses to expectancy and experience of monetary gains and losses, Neuron, 30, 619, 2001.
138. Breiter, H.C. and Rosen, B.R., Functional magnetic resonance imaging of brain reward circuitry in the human, Ann. NY Acad. Sci., 877, 523, 1999.
139. Chen, Y.I. et al., Improved mapping of pharmacologically induced neuronal activation using superparamagnetic iron blood pool agents, in Proc. Intl. Soc. Mag. Res. Med., 1999, p. 348.
140. Kaufman, M.J. et al., Cocaine-induced cerebral vasoconstriction differs as a function of sex and menstrual cycle phase, Biol. Psychiatr., 49, 774, 2001.
141. Breiter, H.C. et al., Acute effects of cocaine on human brain activity and emotion, Neuron, 19, 591, 1997.
142. Maas, L.C. et al., Functional magnetic resonance imaging of human brain activation during cue-induced cocaine craving, Am. J. Psychiatr., 155, 124, 1998.
143. Garavan, H. et al., Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli, Am. J. Psychiatr., 157, 1789, 2000.
144. Volkow, N.D. and Fowler, J.S., Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex, Cereb. Cortex, 10, 318, 2000.
145. Morgan, D. et al., Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration, Nature Neurosci., 5, 169, 2002.
146. Nestler, E.J., Molecular neurobiology of addiction, Am. J. Addict., 10, 201, 2001.
147. Elman, I. et al., Clinical outcomes following cocaine infusion in nontreatment-seeking individuals with cocaine dependence, Biol. Psychiatr., 49, 553, 2001.
148. Bradberry, C.W. et al., Impact of self-administered cocaine and cocaine cues on extracellular dopamine in mesolimbic and sensorimotor striatum in rhesus monkeys, J. Neurosci., 20, 3874, 2000.
149. Nyback, H. et al., Attempts to visualize nicotinic receptors in the brain of monkey and man by positron emission tomography, Progr. Brain Res., 79, 313, 1989.
150. Domino, E.F. et al., Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers, Synapse, 38, 313, 2000.
151. Zubieta, J. et al., Regional cerebral blood flow effects of nicotine in overnight abstinent smokers, Biol. Psychiatr., 49, 906, 2001.
152. Sell, L.A. et al., Neural responses associated with cue evoked emotional states and heroin in opiate addicts, Drug Alcohol Depend., 60, 207, 2000.
153. Trusk, T.C. and Stein, E.A., Effect of intravenous heroin and naloxone on regional cerebral blood flow in the conscious rat, Brain Res., 406, 238, 1987.
154. Fuller, S.A. and Stein, E.A., Effects of heroin and naloxone on cerebral blood flow in the conscious rat, Pharmacol. Biochem. Behav., 40, 339, 1991.
155. Robinson, T.E., Castaneda, E., and Whishaw, I.Q., Compensatory changes in striatal dopamine neurons following recovery from injury induced by 6-OHDA or metham-phetamine: a review of evidence from microdialysis studies, Can. J. Psychol., 44, 253, 1990.
156. Singer, T.P and Ramsay, R.R., Mechanism of the neurotoxicity of MPTP: an update, FEBS Lett, 274, 1, 1990.
157. Brownell, A.-L. et al., Cocaine congeners as PET imaging probes for dopamine terminals in normal and MPTP induced parkinsonism in nonhuman primate brain, J. Nucl. Med, 37, 1186, 1996.